Cullinan Therapeutics Inc
XNAS:CGEM 4:00:00 PM EDT
| Market Cap (Intraday) | 637.98M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $10.30 |
| 50-Day MA | $9.59 |
| 200-Day MA | $8.15 |
Cullinan Therapeutics Inc Stock, XNAS:CGEM
One Main Street, Suite 1350, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.410.4650
Number of Employees: 111
Description
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.